期刊文献+

混合型肝细胞-胆管细胞癌的外科治疗效果及预后分析 被引量:1

Surgical Outcome and Prognostic Factor Analysis for Combined Hepatocellular and Cholangiocarcinoma
下载PDF
导出
摘要 目的探讨混合型肝细胞-胆管细胞癌的临床特征、诊断及外科治疗效果。方法 2000年1月~2010年12月间中国医学科学院肿瘤医院经手术病理学检查证实的混合型肝细胞-胆管细胞癌患者23例,对其临床、病理、生存情况以及复发情况等相关资料进行回顾性分析。结果 23例患者中有22例接受剖腹探查肝切除术或联合淋巴结清扫术(7例),另外1例采用腹腔镜下肝脏肿瘤切除术。除1例围手术期死亡外,其余22例患者中16例出现复发。术后中位生存时间及中位无复发生存时间分别为15.00(0.37~116.00)及5.00(0.37~116.00)个月;1、3、5年的总体生存率及无复发生存率分别为62.7%,35.8%,23.9%和40.9%,30.7%,15.3%。复发后患者的中位生存时间仅为5.04(1.5~65.0)个月。将可能影响患者预后的因素进行单因素分析及Log-rank检验,结果显示:肝炎肝硬化合并长期饮酒、术中输血、手术切缘阳性、病理分期较晚以及影响分期的因素如肿瘤直径>5cm、多发肿瘤等多个因素与患者的不良预后有关,而CEA>5ng/ml、肿瘤穿透肝被膜等同样可能影响患者生存。结论本病缺乏特异性临床表现,术前明确诊断较为困难。混合型肝细胞-胆管细胞癌预后不佳。根治性手术是其有效治疗手段,这其中多个因素与不良的预后有关。 Objective To evaluate the clinical manifestations, diagnostic procedures and surgical treatment of combined hepatocel lular and cholangiocarcinoma (cHCC CC). Methods The clinical materials of twenty three surgically treated patients with cHCC CC over a 11 year period were retrospectively analyzed. Results Among the 23 cases, 22 of which underwent liver resection by laparot omy with curative intent including 7 cases received lymphadenectomy, and the other 1 patient received hepatic resection by laparoscopy. After resection, there was 1 perioperative death. The overall median survival time was 15.00(0.37 116.00) months, and the 1 ,3 and 5 year overall survival rates were 62.7% ,35.8% and 23.9% , respectively. There are 16 patients showed tumor recurrence and the median Disease free survival (DFS) time was 5.00 (0.37 116.00) months. DFS rates at 1 year, 3 year and 5 year were 40.9% , 30. 7% , i5.3% , respectively. After recurrence,the median survival time was only 5.04 ( 1.5 65. O) months. Univariate analysis re vealed that past history of chronic alcohol abuse,intraoperative blood transfusin,tumor size 〉 5cm,multiplicity, and later TNM staging ex hibited adverse influence on survival and recurrence. We also found that the liver capsule perforated and CEA 〉 5ng/ml were also probably correlated with worse prognoses. Conclusion The cHCC CC is uncommon and lack of typical clinical manifestations, making the pre operative accurate diagnosis appeared to be very difficult with conventional radiography. Extensive surgery is an effective treatment for this disease. After resection, the recurrence is common and the survival rates are poor. Quite a few factors may affect the survival and recur rence. More cases are needed to further define the characteristics of this tumor.
出处 《医学研究杂志》 2012年第5期97-101,共5页 Journal of Medical Research
关键词 混合型肝细胞-胆管细胞癌 肝癌 胆管细胞癌 肝切除术 Combined hepatocellular and cholangiocarcinoma Hepatocellular carcinoma Cholangiocarcinoma Hepatectomy
  • 相关文献

参考文献17

  • 1Kassahun WT, Hauss J. Management of combined hepatocellular and cholangiocarcinoma[ J]. Int J Clin Pract, 2008,62(8) : 1271 -1278.
  • 2Tang D, Nagano H, Nakamura M, et al. Clinical and pathological features of Alien's type C classification of resected combined hepato- cellular and cholangiocarcinoma: a comparative study with hepatocel- lular carcinoma and cholangiocellular carcinoma [ J]. J Gastrointest Surg, 2006, 10(7) : 987 -998.
  • 3Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma[ J].Am J Pathol, 1949, 25(4) : 647 -655.
  • 4Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellu- lar - cholangiocarcinoma. A histologic and immunohistochemical study [J]. Cancer, 1985,55(1): 124 -135.
  • 5Aishima S, Kuroda Y, Asayama Y, et al. Prognostic impact of cholangiocellular and sarcomatous components in combined hepatocel- lular and cholangiocarcinoma[ J]. Hum Pathol, 2006, 37 (3) : 283 - 291.
  • 6Kim KH, Lee SG, Park EH, et al. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarci- noma[J]. Ann SurgOncol, 2009, 16(3): 623 -629.
  • 7Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases [J]. JpnJClin Oncol, 2003, 33(6): 283 -287.
  • 8Asayama Y, Taguchi KK, Aishima SS, et al. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarci- noma: an immunohistochemical analysis of E - cadherin, alpha - catenin and beta - catenin [ J ]. Liver, 2002, 22 ( 1 ) : 43 - 50.
  • 9Cazals - Harem D, Rebouissou S, Bioulac - Sage P, et al. Clinical and molecular analysis of combined hepatocellular - cholangiocarcino- mas[J]. J nepatol, 2004, 41(2): 292 -298.
  • 10Toh CH, Cheung YC, Ng SH, et al. Combined hepatocellular - cholangiocarcinoma: a case report[ J]. Int J Clin Pract, 2004, 58 (12): 1170-1173.

同被引文献16

  • 1Panjala C,Senecal DL, Bridges MD, et al. The diagnostic conun-drum and liver transplantation outcome for combined hepatocel- lular-cholangiocarcinoma[J]. Am J Transplant, 2010, 10 ( 5 ) : 1263-1267.
  • 2Goodman ZD, lshak KG, Langloss J M, et al.Combined hepatoeel- lular-cholangiocarcinoma. A histologic and immunohistochemical study[J]. Cancer, 1985,55 (1) : 124-129.
  • 3Wachtel MS,Zhang Y,Xu T, et al. Combined hepatocellular cholangio- carcinomas;analysis of a large database[J]. Clin Med Pathol, 2008, 1 (1) :43-47.
  • 4Akiba J, Nakashima O, Hattori S, et al. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification [J]. Am J Surg Pathol, 2013,37 (4) : 496-505.
  • 5Yin X, Zhang BH, Qiu SJ, et al. Combined hepatocellular carcino- ma and cholangiocarcinoma: clinical features, treatment modali- ties,and prognosis[J].Ann Surg Oneol,2012,19(9) :2869-2876.
  • 6Kim KH, Lee SG, Park EH, et al. Surgical treatments and prog- noses of patients with combined hepatocellular carcinoma and cholangiocarcinoma[J]. Ann Surg Oncol, 2009,16 (3): 623-629.
  • 7Wang J,Wang F, Kessinger A. Outcome of combined hepatocel- lular and cholangiocareinoma of the liver [J]. J Oncol, 2010, 2010:917356.
  • 8Sapisochin G, Fidelman N, Roberts JP, et al. Mixed hepatoeellu- lar cholangiocareinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatoeellular carcinoma [J]. Liver Transpl,2011,17(8)..934-942.
  • 9Zhan Q, Shen BY, Deng XX, et al. Clinical and pathological anal- ysis of 27 patients with combined hepatocellular-cholangiocarci- noma in an Asina center[J]. J Hepatobiliary Pancreat Sci, 2012, 19(4) :361-369.
  • 10张磊,蔡建强,毕新宇,赵建军,邢古生,阎涛,付玉霞,赵平.肝内胆管细胞癌患者的预后影响因素分析[J].中华肿瘤杂志,2009,31(11):845-848. 被引量:8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部